0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Anti-Emetic Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-17B7962
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Emetic Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Anti-Emetic Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17B7962
Report
December 2024
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-Emetic Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-Emetic Drug - Market

Anti-Emetic Drug - Market

Anti-emetic drugs are drugs that prevent or reduce nausea and vomiting. Antiemetic drugs inhibit vomiting reactions through different links, including thiazide drugs, antihistamines, and anticholinergics.
The global market for Anti-Emetic Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-Emetic Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-Emetic Drug by region & country, by Type, and by Application.
The Anti-Emetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Emetic Drug.
Market Segmentation

Scope of Anti-Emetic Drug - Market Report

Report Metric Details
Report Name Anti-Emetic Drug - Market
CAGR 5%
Segment by Type:
  • Oral
  • Injection
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Home Care
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Glenmark Pharmaceuticals, F. Hoffmann-La Roche, Heron Therapeutics, Kyowa Kirin, Aurobindo Pharma, Mylan, Hikma, Akorn, Dr. Reddy’s Laboratories, Cipla, Fresenius Kabi, Wockhardt, Sun Pharmaceutical Industries, Teva Pharmaceutical, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Anti-Emetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Anti-Emetic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Anti-Emetic Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti-Emetic Drug - Market report?

Ans: The main players in the Anti-Emetic Drug - Market are Merck, Novartis, Glenmark Pharmaceuticals, F. Hoffmann-La Roche, Heron Therapeutics, Kyowa Kirin, Aurobindo Pharma, Mylan, Hikma, Akorn, Dr. Reddy’s Laboratories, Cipla, Fresenius Kabi, Wockhardt, Sun Pharmaceutical Industries, Teva Pharmaceutical, Pfizer

What are the Application segmentation covered in the Anti-Emetic Drug - Market report?

Ans: The Applications covered in the Anti-Emetic Drug - Market report are Hospital, Clinic, Home Care, Others

What are the Type segmentation covered in the Anti-Emetic Drug - Market report?

Ans: The Types covered in the Anti-Emetic Drug - Market report are Oral, Injection, Others

1 Market Overview
1.1 Anti-Emetic Drug Product Introduction
1.2 Global Anti-Emetic Drug Market Size Forecast
1.2.1 Global Anti-Emetic Drug Sales Value (2019-2030)
1.2.2 Global Anti-Emetic Drug Sales Volume (2019-2030)
1.2.3 Global Anti-Emetic Drug Sales Price (2019-2030)
1.3 Anti-Emetic Drug Market Trends & Drivers
1.3.1 Anti-Emetic Drug Industry Trends
1.3.2 Anti-Emetic Drug Market Drivers & Opportunity
1.3.3 Anti-Emetic Drug Market Challenges
1.3.4 Anti-Emetic Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-Emetic Drug Players Revenue Ranking (2023)
2.2 Global Anti-Emetic Drug Revenue by Company (2019-2024)
2.3 Global Anti-Emetic Drug Players Sales Volume Ranking (2023)
2.4 Global Anti-Emetic Drug Sales Volume by Company Players (2019-2024)
2.5 Global Anti-Emetic Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-Emetic Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-Emetic Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-Emetic Drug
2.9 Anti-Emetic Drug Market Competitive Analysis
2.9.1 Anti-Emetic Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-Emetic Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Emetic Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.1.3 Others
3.2 Global Anti-Emetic Drug Sales Value by Type
3.2.1 Global Anti-Emetic Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-Emetic Drug Sales Value, by Type (2019-2030)
3.2.3 Global Anti-Emetic Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-Emetic Drug Sales Volume by Type
3.3.1 Global Anti-Emetic Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-Emetic Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-Emetic Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-Emetic Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Home Care
4.1.4 Others
4.2 Global Anti-Emetic Drug Sales Value by Application
4.2.1 Global Anti-Emetic Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-Emetic Drug Sales Value, by Application (2019-2030)
4.2.3 Global Anti-Emetic Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-Emetic Drug Sales Volume by Application
4.3.1 Global Anti-Emetic Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-Emetic Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-Emetic Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-Emetic Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-Emetic Drug Sales Value by Region
5.1.1 Global Anti-Emetic Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-Emetic Drug Sales Value by Region (2019-2024)
5.1.3 Global Anti-Emetic Drug Sales Value by Region (2025-2030)
5.1.4 Global Anti-Emetic Drug Sales Value by Region (%), (2019-2030)
5.2 Global Anti-Emetic Drug Sales Volume by Region
5.2.1 Global Anti-Emetic Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-Emetic Drug Sales Volume by Region (2019-2024)
5.2.3 Global Anti-Emetic Drug Sales Volume by Region (2025-2030)
5.2.4 Global Anti-Emetic Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-Emetic Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-Emetic Drug Sales Value, 2019-2030
5.4.2 North America Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-Emetic Drug Sales Value, 2019-2030
5.5.2 Europe Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-Emetic Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-Emetic Drug Sales Value, 2019-2030
5.7.2 South America Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-Emetic Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-Emetic Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-Emetic Drug Sales Value
6.2.1 Key Countries/Regions Anti-Emetic Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-Emetic Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-Emetic Drug Sales Value, 2019-2030
6.3.2 United States Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-Emetic Drug Sales Value, 2019-2030
6.4.2 Europe Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-Emetic Drug Sales Value, 2019-2030
6.5.2 China Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-Emetic Drug Sales Value, 2019-2030
6.6.2 Japan Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-Emetic Drug Sales Value, 2019-2030
6.7.2 South Korea Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-Emetic Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-Emetic Drug Sales Value, 2019-2030
6.9.2 India Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-Emetic Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Anti-Emetic Drug Product Offerings
7.1.5 Merck Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Introduction and Business Overview
7.2.3 Novartis Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis Anti-Emetic Drug Product Offerings
7.2.5 Novartis Recent Development
7.3 Glenmark Pharmaceuticals
7.3.1 Glenmark Pharmaceuticals Company Information
7.3.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.3.3 Glenmark Pharmaceuticals Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Glenmark Pharmaceuticals Anti-Emetic Drug Product Offerings
7.3.5 Glenmark Pharmaceuticals Recent Development
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Information
7.4.2 F. Hoffmann-La Roche Introduction and Business Overview
7.4.3 F. Hoffmann-La Roche Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 F. Hoffmann-La Roche Anti-Emetic Drug Product Offerings
7.4.5 F. Hoffmann-La Roche Recent Development
7.5 Heron Therapeutics
7.5.1 Heron Therapeutics Company Information
7.5.2 Heron Therapeutics Introduction and Business Overview
7.5.3 Heron Therapeutics Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Heron Therapeutics Anti-Emetic Drug Product Offerings
7.5.5 Heron Therapeutics Recent Development
7.6 Kyowa Kirin
7.6.1 Kyowa Kirin Company Information
7.6.2 Kyowa Kirin Introduction and Business Overview
7.6.3 Kyowa Kirin Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kyowa Kirin Anti-Emetic Drug Product Offerings
7.6.5 Kyowa Kirin Recent Development
7.7 Aurobindo Pharma
7.7.1 Aurobindo Pharma Company Information
7.7.2 Aurobindo Pharma Introduction and Business Overview
7.7.3 Aurobindo Pharma Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Aurobindo Pharma Anti-Emetic Drug Product Offerings
7.7.5 Aurobindo Pharma Recent Development
7.8 Mylan
7.8.1 Mylan Company Information
7.8.2 Mylan Introduction and Business Overview
7.8.3 Mylan Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Mylan Anti-Emetic Drug Product Offerings
7.8.5 Mylan Recent Development
7.9 Hikma
7.9.1 Hikma Company Information
7.9.2 Hikma Introduction and Business Overview
7.9.3 Hikma Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hikma Anti-Emetic Drug Product Offerings
7.9.5 Hikma Recent Development
7.10 Akorn
7.10.1 Akorn Company Information
7.10.2 Akorn Introduction and Business Overview
7.10.3 Akorn Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Akorn Anti-Emetic Drug Product Offerings
7.10.5 Akorn Recent Development
7.11 Dr. Reddy’s Laboratories
7.11.1 Dr. Reddy’s Laboratories Company Information
7.11.2 Dr. Reddy’s Laboratories Introduction and Business Overview
7.11.3 Dr. Reddy’s Laboratories Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offerings
7.11.5 Dr. Reddy’s Laboratories Recent Development
7.12 Cipla
7.12.1 Cipla Company Information
7.12.2 Cipla Introduction and Business Overview
7.12.3 Cipla Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Cipla Anti-Emetic Drug Product Offerings
7.12.5 Cipla Recent Development
7.13 Fresenius Kabi
7.13.1 Fresenius Kabi Company Information
7.13.2 Fresenius Kabi Introduction and Business Overview
7.13.3 Fresenius Kabi Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Fresenius Kabi Anti-Emetic Drug Product Offerings
7.13.5 Fresenius Kabi Recent Development
7.14 Wockhardt
7.14.1 Wockhardt Company Information
7.14.2 Wockhardt Introduction and Business Overview
7.14.3 Wockhardt Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Wockhardt Anti-Emetic Drug Product Offerings
7.14.5 Wockhardt Recent Development
7.15 Sun Pharmaceutical Industries
7.15.1 Sun Pharmaceutical Industries Company Information
7.15.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.15.3 Sun Pharmaceutical Industries Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Sun Pharmaceutical Industries Anti-Emetic Drug Product Offerings
7.15.5 Sun Pharmaceutical Industries Recent Development
7.16 Teva Pharmaceutical
7.16.1 Teva Pharmaceutical Company Information
7.16.2 Teva Pharmaceutical Introduction and Business Overview
7.16.3 Teva Pharmaceutical Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Teva Pharmaceutical Anti-Emetic Drug Product Offerings
7.16.5 Teva Pharmaceutical Recent Development
7.17 Pfizer
7.17.1 Pfizer Company Information
7.17.2 Pfizer Introduction and Business Overview
7.17.3 Pfizer Anti-Emetic Drug Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Pfizer Anti-Emetic Drug Product Offerings
7.17.5 Pfizer Recent Development
8 Industry Chain Analysis
8.1 Anti-Emetic Drug Industrial Chain
8.2 Anti-Emetic Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-Emetic Drug Sales Model
8.5.2 Sales Channel
8.5.3 Anti-Emetic Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Anti-Emetic Drug Market Trends
    Table 2. Anti-Emetic Drug Market Drivers & Opportunity
    Table 3. Anti-Emetic Drug Market Challenges
    Table 4. Anti-Emetic Drug Market Restraints
    Table 5. Global Anti-Emetic Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anti-Emetic Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Anti-Emetic Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Anti-Emetic Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anti-Emetic Drug Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Anti-Emetic Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anti-Emetic Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anti-Emetic Drug
    Table 13. Global Anti-Emetic Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Emetic Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-Emetic Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anti-Emetic Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anti-Emetic Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anti-Emetic Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anti-Emetic Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anti-Emetic Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Anti-Emetic Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Anti-Emetic Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Anti-Emetic Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anti-Emetic Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anti-Emetic Drug Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Anti-Emetic Drug Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Anti-Emetic Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anti-Emetic Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anti-Emetic Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anti-Emetic Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anti-Emetic Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anti-Emetic Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Anti-Emetic Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Anti-Emetic Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Anti-Emetic Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anti-Emetic Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anti-Emetic Drug Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Anti-Emetic Drug Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Anti-Emetic Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anti-Emetic Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anti-Emetic Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anti-Emetic Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anti-Emetic Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anti-Emetic Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Anti-Emetic Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Anti-Emetic Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Anti-Emetic Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anti-Emetic Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anti-Emetic Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Anti-Emetic Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Anti-Emetic Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anti-Emetic Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anti-Emetic Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anti-Emetic Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Anti-Emetic Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. Merck Company Information
    Table 58. Merck Introduction and Business Overview
    Table 59. Merck Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Merck Anti-Emetic Drug Product Offerings
    Table 61. Merck Recent Development
    Table 62. Novartis Company Information
    Table 63. Novartis Introduction and Business Overview
    Table 64. Novartis Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Novartis Anti-Emetic Drug Product Offerings
    Table 66. Novartis Recent Development
    Table 67. Glenmark Pharmaceuticals Company Information
    Table 68. Glenmark Pharmaceuticals Introduction and Business Overview
    Table 69. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Glenmark Pharmaceuticals Anti-Emetic Drug Product Offerings
    Table 71. Glenmark Pharmaceuticals Recent Development
    Table 72. F. Hoffmann-La Roche Company Information
    Table 73. F. Hoffmann-La Roche Introduction and Business Overview
    Table 74. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. F. Hoffmann-La Roche Anti-Emetic Drug Product Offerings
    Table 76. F. Hoffmann-La Roche Recent Development
    Table 77. Heron Therapeutics Company Information
    Table 78. Heron Therapeutics Introduction and Business Overview
    Table 79. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Heron Therapeutics Anti-Emetic Drug Product Offerings
    Table 81. Heron Therapeutics Recent Development
    Table 82. Kyowa Kirin Company Information
    Table 83. Kyowa Kirin Introduction and Business Overview
    Table 84. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Kyowa Kirin Anti-Emetic Drug Product Offerings
    Table 86. Kyowa Kirin Recent Development
    Table 87. Aurobindo Pharma Company Information
    Table 88. Aurobindo Pharma Introduction and Business Overview
    Table 89. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Aurobindo Pharma Anti-Emetic Drug Product Offerings
    Table 91. Aurobindo Pharma Recent Development
    Table 92. Mylan Company Information
    Table 93. Mylan Introduction and Business Overview
    Table 94. Mylan Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Mylan Anti-Emetic Drug Product Offerings
    Table 96. Mylan Recent Development
    Table 97. Hikma Company Information
    Table 98. Hikma Introduction and Business Overview
    Table 99. Hikma Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Hikma Anti-Emetic Drug Product Offerings
    Table 101. Hikma Recent Development
    Table 102. Akorn Company Information
    Table 103. Akorn Introduction and Business Overview
    Table 104. Akorn Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Akorn Anti-Emetic Drug Product Offerings
    Table 106. Akorn Recent Development
    Table 107. Dr. Reddy’s Laboratories Company Information
    Table 108. Dr. Reddy’s Laboratories Introduction and Business Overview
    Table 109. Dr. Reddy’s Laboratories Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Dr. Reddy’s Laboratories Anti-Emetic Drug Product Offerings
    Table 111. Dr. Reddy’s Laboratories Recent Development
    Table 112. Cipla Company Information
    Table 113. Cipla Introduction and Business Overview
    Table 114. Cipla Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Cipla Anti-Emetic Drug Product Offerings
    Table 116. Cipla Recent Development
    Table 117. Fresenius Kabi Company Information
    Table 118. Fresenius Kabi Introduction and Business Overview
    Table 119. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Fresenius Kabi Anti-Emetic Drug Product Offerings
    Table 121. Fresenius Kabi Recent Development
    Table 122. Wockhardt Company Information
    Table 123. Wockhardt Introduction and Business Overview
    Table 124. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Wockhardt Anti-Emetic Drug Product Offerings
    Table 126. Wockhardt Recent Development
    Table 127. Sun Pharmaceutical Industries Company Information
    Table 128. Sun Pharmaceutical Industries Introduction and Business Overview
    Table 129. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Sun Pharmaceutical Industries Anti-Emetic Drug Product Offerings
    Table 131. Sun Pharmaceutical Industries Recent Development
    Table 132. Teva Pharmaceutical Company Information
    Table 133. Teva Pharmaceutical Introduction and Business Overview
    Table 134. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Teva Pharmaceutical Anti-Emetic Drug Product Offerings
    Table 136. Teva Pharmaceutical Recent Development
    Table 137. Pfizer Company Information
    Table 138. Pfizer Introduction and Business Overview
    Table 139. Pfizer Anti-Emetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Pfizer Anti-Emetic Drug Product Offerings
    Table 141. Pfizer Recent Development
    Table 142. Key Raw Materials Lists
    Table 143. Raw Materials Key Suppliers Lists
    Table 144. Anti-Emetic Drug Downstream Customers
    Table 145. Anti-Emetic Drug Distributors List
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Emetic Drug Product Picture
    Figure 2. Global Anti-Emetic Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anti-Emetic Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Anti-Emetic Drug Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Anti-Emetic Drug Report Years Considered
    Figure 7. Global Anti-Emetic Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anti-Emetic Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Emetic Drug Revenue in 2023
    Figure 10. Anti-Emetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. Injection Picture
    Figure 13. Others Picture
    Figure 14. Global Anti-Emetic Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Anti-Emetic Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Anti-Emetic Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Anti-Emetic Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Anti-Emetic Drug Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Home Care
    Figure 22. Product Picture of Others
    Figure 23. Global Anti-Emetic Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Anti-Emetic Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Anti-Emetic Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Anti-Emetic Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Anti-Emetic Drug Price by Application (2019-2030) & (US$/Unit)
    Figure 28. North America Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Anti-Emetic Drug Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Anti-Emetic Drug Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Anti-Emetic Drug Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Anti-Emetic Drug Sales Volume (%), (2019-2030)
    Figure 40. United States Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Anti-Emetic Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Anti-Emetic Drug Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Anti-Emetic Drug Sales Value by Application (%), 2023 VS 2030
    Figure 61. Anti-Emetic Drug Industrial Chain
    Figure 62. Anti-Emetic Drug Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS